Healthcare & Life Sciences

Xeptiva

aliveseed
seed
Stage
1
Investors

About

Xeptiva Therapeutics develops first-in-class therapeutic vaccines that actively immunize companion animals against chronic inflammatory conditions such as osteoarthritis, chronic pain, atopic dermatitis, and obesity to improve their healthspan and lifespan.

Explore Xeptiva's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.